Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization

References

• Petruzziello A. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma. Open Virol J. 2018;12(Suppl–1):26–32.
   PubMedGoogle Scholar
• Petruzziello A, Marigliano S, Loquercio G, et al. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22(34):7824–7840.
   PubMed Web of Science ®Google Scholar
• Saraswat VA, Pandey G, Shetty S. Treatment algorithms for managing hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4:S80–S89.
   PubMedGoogle Scholar
• Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–442.
   PubMed Web of Science ®Google Scholar
• Zhou D, Liang J, Xu L, et al. Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization. Oncology Letters. 2016;11:2987–2994.
   PubMed Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.
   PubMed Web of Science ®Google Scholar
• Huo TI, Lee PC, Huang YH, et al. The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy. J Clin Gastroenterol. 2006;40:543–550.
   PubMed Web of Science ®Google Scholar
• D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–231.
   PubMed Web of Science ®Google Scholar
• Delis S, Bakoyiannis A, Madariaga J, et al. Laparoscopic cholecystectomy in cirrhotic patients: the value of MELD score and Child-Pugh classification in predicting outcome. Surg Endosc. 2010;24:407–412.
   PubMed Web of Science ®Google Scholar
• Reichman TW, Bahramipour P, Barone A, et al. Hepatitis status, child-pugh classification, and serum AFP levels predict survival in patients treated with transarterial embolization for unresectable hepatocellular carcinoma. J Gastrointest Surg. 2005;9:638–645.
   PubMed Web of Science ®Google Scholar
• He W, Wei M, Yang X, et al. Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?. Medicine. 2017;96(17):e6607.
   Google Scholar
• Lu A, Li H, Zheng Y, et al. Prognostic significance of neutrophil to lymphocyte, lymphocyte to monocyte ratio, and platelet to lymphocyte ratio in patients with nasopharyngeal carcinoma. Biomed Res Int. 2017;2017:1–6.
   Web of Science ®Google Scholar
• Smirne C, Grossi G, Pinato DJ, et al. Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma. Dig Liver Dis. 2015;47:488–494.
   PubMedGoogle Scholar
• Zhou D, Zhang Y, Xu L, et al. A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma. Sci Rep. 2015;5(15263):1–9.
   Google Scholar
• European Association for the Study of the Liver. European Organisation for Research and Treatment of Cancer: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52–60.
   PubMed Web of Science ®Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649.
   PubMed Web of Science ®Google Scholar
• Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871.
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? The Lancet. 2001;357:539–545.
   PubMed Web of Science ®Google Scholar
• McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Nutr Metab Care. 2009;12:223–226.
   PubMed Web of Science ®Google Scholar
• Oh BS, Jang JW, Kwon JH, et al. Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma. BMC Cancer. 2013;15(13):78.
   Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–899.
   PubMed Web of Science ®Google Scholar
• Maxwell PJ, Coulter J, Walker SM, et al. Potentiation of Inflammatory CXCL8 Signalling Sustains Cell Survival in PTEN-deficient Prostate Carcinoma. Eur Urol. 2013;64:177–188.
   PubMed Web of Science ®Google Scholar
• Sivaramakrishnan V, Devaraj NS. Morin regulates the expression of NF-κB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chem Biol Interact. 2009;180:353–359.
   PubMed Web of Science ®Google Scholar
• Liu S, Li N, Yu X, et al. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells. Gastroenterol. 2013;144:1031–1041.
   PubMed Web of Science ®Google Scholar
• Halazun KJ, Hardy MA, Rana AA, et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg. 2009;250:141–151.
   PubMed Web of Science ®Google Scholar
• Kuang DM, Zhao Q, Wu Y, et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol. 2011 May;54(5):948–55.
   Google Scholar
• Pr D, An X, Rx Z, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis. 2010;25:1427–1433.
   PubMed Web of Science ®Google Scholar
• Chew V, Tow C, Teo M, et al. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients. J Hepatol. 2010;52:370–379.
   PubMed Web of Science ®Google Scholar
• Hu YC, Yi ZJ, Zhou Y, et al. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF-κB-mediated alternative polarization of macrophages. Oncol Rep. 2017;37:2971–2979.
   PubMed Web of Science ®Google Scholar
• Jackaman C, Tomay F, Duong L, et al. Aging and cancer: the role of macrophages and neutrophils. Ageing Res Rev. 2017;36:105–116.
   PubMed Web of Science ®Google Scholar
• Yan C, Yang Q, Tumor-Associated Neutrophils GZ. Macrophages promote gender disparity in hepatocellular carcinoma in zebrafish. Cancer Res. 2017;77:1395–1407.
   PubMed Web of Science ®Google Scholar
• Farinati F, Rinaldi M, Gianni S, et al. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer. 2000;89:2266–2273.
   PubMed Web of Science ®Google Scholar
• Song PP, Xia JF, Inagaki Y, et al. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol. 2016;22:262–274.
   PubMed Web of Science ®Google Scholar
• Tang H, Tang X, Liu M, et al. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle. Clin Chim Acta. 2008;394:81–88.
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhu M, Li W, et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells. J Cell Mol Med. 2016;20:549–558.
   PubMed Web of Science ®Google Scholar
• Grąt M, Krasnodębski M, Patkowski W, et al. Relevance of Pre-Transplant α-fetoprotein Dynamics in Liver Transplantation for Hepatocellular Cancer. Ann Transplant. 2016;21:115–124.
   PubMed Web of Science ®Google Scholar
• Dohmen K, Shirahama M, Shigematsu H, et al. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2004;19:859–865.
   PubMed Web of Science ®Google Scholar
• Borzio M, Dionigi E, Parisi G, et al. Management of hepatocellular carcinoma in the elderly. World J Hepatol. 2015;7:1521–1529.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ye L, Zhang J, et al. MELD scores and Child–pugh classifications predict the outcomes of ERCP in cirrhotic patients with choledocholithiasis: a retrospective cohort study. Medicine. 2015;94:e433–e439.
   PubMed Web of Science ®Google Scholar
• Attallah AM, Omran D, Omran MM, et al. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients. Br J Biomed Sci. 2018;75:19–23.
   PubMed Web of Science ®Google Scholar
• Farid K, Omran MM, Farag RE, et al. Development and evaluation of a novel score for prediction of large oesophageal varices in patients with hepatitis c virus-induced liver cirrhosis. Br J Biomed Sci. 2017;74:138–214.
   PubMed Web of Science ®Google Scholar
• Attallah AM, El-Far M, Abdelrazek MA, et al. Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients. Br J Biomed Sci. 2017;74:170–175.
   PubMed Web of Science ®Google Scholar